Witnesses Seek 15% Boost For NCI In 1998 as First Step to 100% Raise Over 5 Years
In Brief: visco Named to Cancer Policy Board; Foundation Pledges $6.5 Million to Karmanos
In This Issue: Congressional Testimony On NIH, NCI Appropriations, FDA Reform
Patient Advocates; NBCC Delivers 2.6M Signatures, demands 2.6Billion
NIH director; Targets Increases Favor Established Researchers
Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA
National Academy elects New Members
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Brown University reaches agreement with Trump administration to restore funding
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science









